Effect of CD14 promoter polymorphism and H. pylori infection and its clinical outcomes on circulating CD14

Clinical and Experimental Immunology

Volumn 128, Issue 2, 2002, Pages 326-332

  Karhukorpi, J ^a,b   Yan, Y ^a   Niemela S ^a,c   Valtonen, J ^d   Koistinen, P ^d   Joensuu, T ^d   Saikku, P ^a   Karttunen, R ^a  

^a UNIVERSITY OF OULU   (Finland)

^b OULU UNIVERSITY HOSPITAL   (Finland)

^c OULU DEACONESS INSTITUTE   (Finland)

^d Oulu City Hospital   (Finland)

Author keywords

CD14; Helicobacter Pylori; Polymorphism

Indexed keywords

CD14 ANTIGEN; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ALLELE; ANTIGEN DETECTION; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; DRUG USE; DUODENUM ULCER; DYSPEPSIA; ENDOSCOPY; ENVIRONMENTAL FACTOR; ENZYME IMMUNOASSAY; ESOPHAGITIS; FEMALE; GASTRITIS; GASTROSCOPY; GENOTYPE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HEREDITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; SEROLOGY; STOMACH EROSION; STOMACH ULCER;

ADULT; AGED; ANTIGENS, CD14; BASE SEQUENCE; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MONOCYTES; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS);

EID: 0036094954     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2002.01837.x     Document Type: Article

References (44)

1. CD14-dependent clearance of apoptotic cells: Relevance to the immune system
2. Dendritic-cell function in Toll-like receptor- and MyD88-knockout mice
3. Expression of CD14 by hepatocytes: Upregulation by cytokines during endotoxemia
4. Hepatocytes contribute to soluble CD14 production, and CD14 expression is differentially regulated in hepatocytes and monocytes
5. A polymorphism in the 5′ flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E
6. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein
7. Recombinant soluble CD14 mediates the activation of endothelial cells by lipopolysaccharide
8. Endotocin activates human vascular smooth muscle cells despite lack of expression of CD14 mRNA or endogenous membrane CD14
9. Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipolysaccharide-binding protein and soluble CD14
10. Lipopolysaccharide induces apoptosis in a bovine endothelial cell line via a soluble CD14 dependent pathway
11. Lipopolysaccharide induces the antiapoptotic molecules, A1 and A20, in microvascular endothelial cells
12. Increased levels of soluble CD14 in sera of periodontitis patients
13. Serum concentrations of lipopolysaccharide activity-modulating proteins during tuberculosis
14. Soluble CD14 levels in the serum, synovial fluid, and cerebrospinal fluid of patients with various stages of Lyme disease
15. Increased levels of circulating soluble CD14 in Kawasaki disease
16. Increased circulating soluble CD14 is associated with high mortality in gram-negative septic shock
17. Function of soluble CD14 in serum from patients with septic shock
18. Risk factors for coronary heart disease and infection with Helicobacter pylori: Meta-analysis of 18 studies
19. Helicobacter pylori lipopolysaccharide binds to CD14 and stimulates release of interleukin-8, epithelial neutrophil-activating peptide 78, and monocyte chemotactic protein 1 by human monocytes
20. Detection of Helicobacter pylori gene expression in human gastric mucosa
21. Relationship betweenHelicobacter pylori iceA, cagA, and vacA status and clinical outcome: Studies in four different countries
22. Allelic variation in the cagA gene of Helicobacter pylori obtained from Korea compared to the United States
23. C(-260)→T polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarction
24. Helicobacter pylori lipopolysaccharide-mediated gastric and extragastric pathology
25. Induction of acute gastritis and epithelial apoptosis by Helicobacter pylori lipopolysaccharide
26. Human B cell function is regulated by interaction with soluble CD14: Opposite effects on IgG1 and IgE production
27. Soluble CD14 acts as a negative regulator of human T cell activation and function
28. Polymorphism in the promoter of lipopolysaccharide receptor CD14 and ischemic cerebrovascular disease
29. Helicobacter pylori gastritis: Pathology and progression
30. Human monocyte CD14 is upregulated by lipopolysaccharide
31. Soluble CD14 acts as a shuttle in the neutralization of lipopolysaccharide (LPS) by LPS-binding protein and reconstituted high density lipoprotein
32. Lipopolysaccharide binding protein and soluble CD14 catalyze exchange of phospholipids
33. Infection and inflammation-induced proatherogenic changes of lipoproteins
34. Association ofHelicobacter pylori infection with elevated serum lipids
35. Could Helicobacter pylori infection increase the risk of coronary heart disease by modifying serum lipid concentrations?
36. Circulating monocytes in patients with diabetes mellitus, arterial disease, and increased CD14 expression
37. A more mature phenotype of blood mononuclear phagocytes is induced by fluvastatin treatment in hypercholesterolemic patients with coronary heart disease
38. Soluble CD14 mediates efflux of phospholipids from cells
39. Common polymorphism in the promoter of the CD14 monocyte receptor gene is associated with acute myocardial infarction in Japanese men
40. A new promoter polymorphism in the gene of lipopolysaccharide receptor CD14 is associated with low expired myocardial infarction in patients with low atherosclerotic risk profile
41. Concordant occurrence of gastric and hypertensive diseases
42. Role of infections in atherosclerosis
43. Association of a promoter polymorphism of the CD14 gene and atopy
44. Exposure of foodborne and orofecal microbes versus airborne viruses in relation to atopy and allergic asthma: Epidemiological study